Lucy Scientific Discovery Inc.
LSDI · NASDAQ
6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 36.2% | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $6 | $3 | $3 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$0 | $0 |
| Operating Expenses | $6 | $3 | $3 | $3 |
| Operating Income | -$6 | -$4 | -$2 | -$3 |
| % Margin | -82,919.7% | – | – | – |
| Other Income/Exp. Net | -$3 | -$2 | -$2 | -$1 |
| Pre-Tax Income | -$9 | -$6 | -$5 | -$4 |
| Tax Expense | $0 | $0 | $2 | -$1 |
| Net Income | -$9 | -$6 | -$7 | -$3 |
| % Margin | -127,532% | – | – | – |
| EPS | -0.71 | -0.38 | -0.44 | -0.19 |
| % Growth | -86.8% | 13.6% | -131.6% | – |
| EPS Diluted | -0.71 | -0.38 | -0.44 | -0.19 |
| Weighted Avg Shares Out | 13 | 16 | 16 | 16 |
| Weighted Avg Shares Out Dil | 13 | 16 | 16 | 16 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $2 | $2 | $0 |
| Interest Expense | $2 | $2 | $2 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$6 | -$3 | -$2 | -$3 |
| % Margin | -80,360.6% | – | – | – |